Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rezwanul Hasan Rana, Khorshed Alam, Syed Afroz Keramat & Jeff Gow. (2022) Cost-effectiveness of single-inhaler triple therapy for patients with severe COPD: a systematic literature review. Expert Review of Respiratory Medicine 16:10, pages 1067-1084.
Read now
Read now
Caroline Sirois, Amina Ouali & Marc Simard. (2019) Polypharmacy among Older Individuals with COPD: Trends between 2000 and 2015 in Quebec, Canada. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:3-4, pages 234-239.
Read now
Read now
B. Ding & A Enstone. (2016) Asthma and chronic obstructive pulmonary disease overlap syndrome (ACOS): structured literature review and physician insights. Expert Review of Respiratory Medicine 10:3, pages 363-371.
Read now
Read now
Mia Nielsen, Camilla Boslev Bårnes & Charlotte Suppli Ulrik. (2015) Clinical characteristics of the asthma–COPD overlap syndrome – a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1443-1454.
Read now
Read now
Articles from other publishers (7)
Malin Axelsson, Helena Backman, Bright I. Nwaru, Caroline Stridsman, Lowie Vanfleteren, Linnea Hedman, Päivi Piirilä, Juuso Jalasto, Arnulf Langhammer, Hannu Kankaanranta, Madeleine Rådinger, Linda Ekerljung, Eva Rönmark & Anne Lindberg. (2023) Underdiagnosis and misclassification of COPD in Sweden – A Nordic Epilung study. Respiratory Medicine 217, pages 107347.
Crossref
Crossref
Priyanka Choudhury, Souvik Biswas, Gyanendra Singh, Arijit Pal, Nilanjana Ghosh, Atul Kumar Ojha, Soumen Das, Gorachand Dutta & Koel Chaudhury. (2022) Immunological profiling and development of a sensing device for detection of IL-13 in COPD and asthma. Bioelectrochemistry 143, pages 107971.
Crossref
Crossref
A Tee, WL Chow, C Burke & B Guruprasad. (2018) Cost-effectiveness of indacaterol/glycopyrronium in comparison with salmeterol/fluticasone combination for patients with moderate-to-severe chronic obstructive pulmonary disease: a LANTERN population analysis from Singapore. Singapore Medical Journal 59:7, pages 383-389.
Crossref
Crossref
M. Reza Maleki-Yazdi, Mathieu Molimard, Dorothy L. Keininger, Jean-Bernard Gruenberger, Joao Carrasco, Claudia Pitotti, Elsa Sauvage, Sara Chehab & David Price. (2016) Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal. Applied Health Economics and Health Policy 14:5, pages 579-594.
Crossref
Crossref
Joan B. Soriano & David Price. 2015. Controversies in COPD. Controversies in COPD
1
25
.
H. Pite, A.M. Pereira, M. Morais-Almeida, C. Nunes, J. Bousquet & J.A. Fonseca. (2014) Prevalence of asthma and its association with rhinitis in the elderly. Respiratory Medicine 108:8, pages 1117-1126.
Crossref
Crossref
Rupert C M Jones, David Price, Dermot Ryan, Erika J Sims, Julie von Ziegenweidt, Laurence Mascarenhas, Anne Burden, David M G Halpin, Robert Winter, Sue Hill, Matt Kearney, Kevin Holton, Anne Moger, Daryl Freeman, Alison Chisholm & Eric D Bateman. (2014) Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. The Lancet Respiratory Medicine 2:4, pages 267-276.
Crossref
Crossref